Global Meningococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Meningococcal Polysaccharide Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Meningococcal polysaccharide diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by certain groups of meningococcal bacteria.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Meningococcal Polysaccharide Vaccine industry chain, the market status of 6 Months-15Year (Polysaccharide Meningtitis AC, Meningitis ACYW), over 3 Year (Polysaccharide Meningtitis AC, Meningitis ACYW), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Meningococcal Polysaccharide Vaccine.

Regionally, the report analyzes the Meningococcal Polysaccharide Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Meningococcal Polysaccharide Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Meningococcal Polysaccharide Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Meningococcal Polysaccharide Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Polysaccharide Meningtitis AC, Meningitis ACYW).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Meningococcal Polysaccharide Vaccine market.

Regional Analysis: The report involves examining the Meningococcal Polysaccharide Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Meningococcal Polysaccharide Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Meningococcal Polysaccharide Vaccine:
Company Analysis: Report covers individual Meningococcal Polysaccharide Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Meningococcal Polysaccharide Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (6 Months-15Year, over 3 Year).

Technology Analysis: Report covers specific technologies relevant to Meningococcal Polysaccharide Vaccine. It assesses the current state, advancements, and potential future developments in Meningococcal Polysaccharide Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Meningococcal Polysaccharide Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Meningococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Market segment by Application
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

Major players covered
    Sanofi
    Bio-Med
    CanSinoBIO
    Walvax Biotechnology
    Chongqing Zhifei Biological
    Chengdu Kanghua Biological Products
    Changsheng Biotechnology
    CanSinoBIO

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of Meningococcal Polysaccharide Vaccine from 2019 to 2024.
Chapter 3, the Meningococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Meningococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe Meningococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Meningococcal Polysaccharide Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Polysaccharide Meningtitis AC
        1.3.3 Meningitis ACYW
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Meningococcal Polysaccharide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 6 Months-15Year
        1.4.3 over 3 Year
        1.4.4 over 2 Year
        1.4.5 over 3 Months
    1.5 Global Meningococcal Polysaccharide Vaccine Market Size & Forecast
        1.5.1 Global Meningococcal Polysaccharide Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030)
        1.5.3 Global Meningococcal Polysaccharide Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Meningococcal Polysaccharide Vaccine Product and Services
        2.1.4 Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 Bio-Med
        2.2.1 Bio-Med Details
        2.2.2 Bio-Med Major Business
        2.2.3 Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
        2.2.4 Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bio-Med Recent Developments/Updates
    2.3 CanSinoBIO
        2.3.1 CanSinoBIO Details
        2.3.2 CanSinoBIO Major Business
        2.3.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        2.3.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 CanSinoBIO Recent Developments/Updates
    2.4 Walvax Biotechnology
        2.4.1 Walvax Biotechnology Details
        2.4.2 Walvax Biotechnology Major Business
        2.4.3 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        2.4.4 Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Walvax Biotechnology Recent Developments/Updates
    2.5 Chongqing Zhifei Biological
        2.5.1 Chongqing Zhifei Biological Details
        2.5.2 Chongqing Zhifei Biological Major Business
        2.5.3 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
        2.5.4 Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Chongqing Zhifei Biological Recent Developments/Updates
    2.6 Chengdu Kanghua Biological Products
        2.6.1 Chengdu Kanghua Biological Products Details
        2.6.2 Chengdu Kanghua Biological Products Major Business
        2.6.3 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
        2.6.4 Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Chengdu Kanghua Biological Products Recent Developments/Updates
    2.7 Changsheng Biotechnology
        2.7.1 Changsheng Biotechnology Details
        2.7.2 Changsheng Biotechnology Major Business
        2.7.3 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
        2.7.4 Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Changsheng Biotechnology Recent Developments/Updates
    2.8 CanSinoBIO
        2.8.1 CanSinoBIO Details
        2.8.2 CanSinoBIO Major Business
        2.8.3 CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
        2.8.4 CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 CanSinoBIO Recent Developments/Updates

3 Competitive Environment: Meningococcal Polysaccharide Vaccine by Manufacturer
    3.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
        3.4.2 Top 6 Meningococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
    3.5 Meningococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Meningococcal Polysaccharide Vaccine Market: Region Footprint
        3.5.2 Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
        3.5.3 Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Meningococcal Polysaccharide Vaccine Market Size by Region
        4.1.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
    4.2 North America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.3 Europe Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.5 South America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)
    4.6 Middle East and Africa Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2030)
    5.3 Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2030)
    6.3 Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America Meningococcal Polysaccharide Vaccine Market Size by Country
        7.3.1 North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe Meningococcal Polysaccharide Vaccine Market Size by Country
        8.3.1 Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Meningococcal Polysaccharide Vaccine Market Size by Region
        9.3.1 Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America Meningococcal Polysaccharide Vaccine Market Size by Country
        10.3.1 South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Meningococcal Polysaccharide Vaccine Market Size by Country
        11.3.1 Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Meningococcal Polysaccharide Vaccine Market Drivers
    12.2 Meningococcal Polysaccharide Vaccine Market Restraints
    12.3 Meningococcal Polysaccharide Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Meningococcal Polysaccharide Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Meningococcal Polysaccharide Vaccine
    13.3 Meningococcal Polysaccharide Vaccine Production Process
    13.4 Meningococcal Polysaccharide Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Meningococcal Polysaccharide Vaccine Typical Distributors
    14.3 Meningococcal Polysaccharide Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Meningococcal Polysaccharide Vaccine Product and Services
    Table 6. Sanofi Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 9. Bio-Med Major Business
    Table 10. Bio-Med Meningococcal Polysaccharide Vaccine Product and Services
    Table 11. Bio-Med Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Bio-Med Recent Developments/Updates
    Table 13. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 14. CanSinoBIO Major Business
    Table 15. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 16. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. CanSinoBIO Recent Developments/Updates
    Table 18. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 19. Walvax Biotechnology Major Business
    Table 20. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 21. Walvax Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Walvax Biotechnology Recent Developments/Updates
    Table 23. Chongqing Zhifei Biological Basic Information, Manufacturing Base and Competitors
    Table 24. Chongqing Zhifei Biological Major Business
    Table 25. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Product and Services
    Table 26. Chongqing Zhifei Biological Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Chongqing Zhifei Biological Recent Developments/Updates
    Table 28. Chengdu Kanghua Biological Products Basic Information, Manufacturing Base and Competitors
    Table 29. Chengdu Kanghua Biological Products Major Business
    Table 30. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Product and Services
    Table 31. Chengdu Kanghua Biological Products Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Chengdu Kanghua Biological Products Recent Developments/Updates
    Table 33. Changsheng Biotechnology Basic Information, Manufacturing Base and Competitors
    Table 34. Changsheng Biotechnology Major Business
    Table 35. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Product and Services
    Table 36. Changsheng Biotechnology Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Changsheng Biotechnology Recent Developments/Updates
    Table 38. CanSinoBIO Basic Information, Manufacturing Base and Competitors
    Table 39. CanSinoBIO Major Business
    Table 40. CanSinoBIO Meningococcal Polysaccharide Vaccine Product and Services
    Table 41. CanSinoBIO Meningococcal Polysaccharide Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. CanSinoBIO Recent Developments/Updates
    Table 43. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Doses)
    Table 44. Global Meningococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Meningococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
    Table 46. Market Position of Manufacturers in Meningococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Meningococcal Polysaccharide Vaccine Production Site of Key Manufacturer
    Table 48. Meningococcal Polysaccharide Vaccine Market: Company Product Type Footprint
    Table 49. Meningococcal Polysaccharide Vaccine Market: Company Product Application Footprint
    Table 50. Meningococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
    Table 51. Meningococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 53. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 54. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (US$/Dose)
    Table 57. Global Meningococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (US$/Dose)
    Table 58. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 59. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 60. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (US$/Dose)
    Table 63. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (US$/Dose)
    Table 64. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 65. Global Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 66. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (US$/Dose)
    Table 69. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (US$/Dose)
    Table 70. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 71. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 72. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 73. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 74. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 75. North America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 76. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 79. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 80. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 81. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 82. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 83. Europe Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 84. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 87. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 88. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 89. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 90. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 91. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 92. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 95. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 96. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 97. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 98. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Doses)
    Table 99. South America Meningococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Doses)
    Table 100. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Meningococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Doses)
    Table 103. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Doses)
    Table 104. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Doses)
    Table 105. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Doses)
    Table 106. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Doses)
    Table 107. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Doses)
    Table 108. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Meningococcal Polysaccharide Vaccine Raw Material
    Table 111. Key Manufacturers of Meningococcal Polysaccharide Vaccine Raw Materials
    Table 112. Meningococcal Polysaccharide Vaccine Typical Distributors
    Table 113. Meningococcal Polysaccharide Vaccine Typical Customers
List of Figures
    Figure 1. Meningococcal Polysaccharide Vaccine Picture
    Figure 2. Global Meningococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type in 2023
    Figure 4. Polysaccharide Meningtitis AC Examples
    Figure 5. Meningitis ACYW Examples
    Figure 6. Global Meningococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application in 2023
    Figure 8. 6 Months-15Year Examples
    Figure 9. over 3 Year Examples
    Figure 10. over 2 Year Examples
    Figure 11. over 3 Months Examples
    Figure 12. Global Meningococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Meningococcal Polysaccharide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Meningococcal Polysaccharide Vaccine Sales Quantity (2019-2030) & (K Doses)
    Figure 15. Global Meningococcal Polysaccharide Vaccine Average Price (2019-2030) & (US$/Dose)
    Figure 16. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2023
    Figure 17. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Manufacturer in 2023
    Figure 18. Producer Shipments of Meningococcal Polysaccharide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 19. Top 3 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 20. Top 6 Meningococcal Polysaccharide Vaccine Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 22. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 23. North America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 24. Europe Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 25. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 26. South America Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 27. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
    Figure 28. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 29. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2019-2030)
    Figure 30. Global Meningococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (US$/Dose)
    Figure 31. Global Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 32. Global Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Application (2019-2030)
    Figure 33. Global Meningococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (US$/Dose)
    Figure 34. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 35. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 36. North America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 37. North America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 38. United States Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Canada Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Mexico Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 42. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 43. Europe Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 44. Europe Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 45. Germany Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. France Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. United Kingdom Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Russia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Italy Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 51. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 52. Asia-Pacific Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 53. Asia-Pacific Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 54. China Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. Japan Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Korea Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. India Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. Southeast Asia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Australia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 61. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 62. South America Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
    Figure 63. South America Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
    Figure 64. Brazil Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 65. Argentina Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
    Figure 67. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
    Figure 68. Middle East & Africa Meningococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
    Figure 69. Middle East & Africa Meningococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
    Figure 70. Turkey Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. Egypt Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Saudi Arabia Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. South Africa Meningococcal Polysaccharide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. Meningococcal Polysaccharide Vaccine Market Drivers
    Figure 75. Meningococcal Polysaccharide Vaccine Market Restraints
    Figure 76. Meningococcal Polysaccharide Vaccine Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Polysaccharide Vaccine in 2023
    Figure 79. Manufacturing Process Analysis of Meningococcal Polysaccharide Vaccine
    Figure 80. Meningococcal Polysaccharide Vaccine Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Companies Mentioned

Sanofi
Bio-Med
CanSinoBIO
Walvax Biotechnology
Chongqing Zhifei Biological
Chengdu Kanghua Biological Products
Changsheng Biotechnology
CanSinoBIO